| 摘要 |
The present invention relates to the use of azapirone compounds for preparing pharmaceutical compositions for the treatment of substance addiction, comprising over-eating, eating disorders, habitual use of tobacco, marihuana, cocaine, opiates, methadone, amphetamines, methylphenidate and related designer drugs and other recreational drugs. |
